Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESUS-AMI intracoronary rhIGF-1 after STEMI
NL-OMON40846Phase 3Withdrawn
- Sponsor
- Centre for Research in Vascular Biology
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mecasermin in myocardial infarction (MI) and heart failure (HF) (3 arms), sponsored by Centre for Research in Vascular Biology. Planned start Aug 2014; status: withdrawn.
02
Drugs
mecasermin
03
Conditions
myocardial infarction (MI)heart failure (HF)
Beyond the preview
Go deeper on NL-OMON40846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40846.